ClinicalTrials.gg
Drug

Epirubicin clinical trials

Also written Ellence and Farmorubicin.

studies test it
155
open now
15
in phase 3
50
first study started
1991
Related medicines add 2 studies

Counted the way a researcher would: Epirubicin with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Epirubicin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Epirubicin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Sept 1999 · ELLENCE · NDA 050778 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Epirubicin
67
epirubicin hydrochloride
45
pharmorubicin
2
Doxorubicin
2
Farmorubicine
2

Brand

Ellence
6
Farmorubicin
3
farmorubicina
1

In one entry with another drug

Given together, or one or the other

Docetaxel and epirubicin
2
docetaxel and epirubicin plus endostatin
2

Studies by the year they started

153 studies that test it; most in 2002 (12)

Studies that test Epirubicin, by start year
YearStudies
19911
19931
19965
19972
19983
19992
20008
200111
200212
200311
20047
20055
20066
20079
200811
20094
20104
20118
20123
20134
20143
20155
20161
20175
20181
20193
20202
20214
20224
20233
20251
20264

Who runs them

Industry 6 · Other 149

Fudan University (7) · Hellenic Oncology Research Group (5) · Cancer Trials Ireland (4) · Royal Marsden NHS Foundation Trust (4) · Hebei Medical University Fourth Hospital (3) · NCIC Clinical Trials Group (3) · NSABP Foundation Inc (3) · SCRI Development Innovations, LLC (3)

Often tested with

Tested in the same studies.

Cyclophosphamide (55) · Docetaxel (48) · Paclitaxel (36) · Fluorouracil (23) · Capecitabine (21) · Cisplatin (19) · Carboplatin (18) · Gemcitabine (9)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 11 phase 3 studies under way

Epirubicin is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 7, 1 in phase 3

Studies that test Epirubicin, phase 3 first.

Studies

Open first, then newest update. How each study uses Epirubicin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 155

See all 155 studies that test Epirubicin →

Given beside what is tested · 133 — Epirubicin is usual care or a partner of the new treatment

Showing 20 of 133.

As the comparator · 49 — what is tested is compared with Epirubicin

Showing 20 of 49.

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Epirubicin · ClinicalTrials.gg INT008452

  • MeSH (NLM) D015251EpirubicinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 3Z8479ZZ5XEPIRUBICINConfirmed FDA, NLM, Wikidata
  • RxNorm 3995Confirmed FDA, Wikidata
  • Wikidata Q425122epirubicinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62028EpirubicinOne source FDA
  • DrugBank DB00445One source Wikidata

Also registered as epirubicin hydrochloride (UNII 22966TX7J5 · RxNorm 203213).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.